APT-101

N/A

Report date: 2022/05/19 15:44:58
NME

Base Information

Drug NameAPT-101
Drug Alias NameAPT101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApelin receptor agonists
TargetsApelin receptor
Therapy Area/IndicationsScleroderma, SystemicIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRti International
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A